Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

cap

Corning Stock Price Skyrockets Since Spin-Off Of Corning Labs

STOCK PRICES of Corning Incorporated have climbed since the divestiture on January 1, 1997 of Corning Clinical Laboratories and Corning Life Sciences into Quest Diagnostics Incorporated and Covance, Inc., respectively. During 1995 a…

Read More



Dynacare Inks New Pact With Milwaukee Hospital

CEO SUMMARY: Dynacare is on the move again. Its latest partnership is with a leading Milwaukee hospital. Dynacare’s aggressive marketing effort to develop joint ventures with hospital laboratories will continue. It may announce more new contracts by year’s end. DEALMAKE…

Read More



Proposed Monthly Test Limit Defeated By United Lab Action

PROPOSALS TO CAP laboratory tests at no more than six per month for MediCal patients in California alarmed clinical laboratories throughout the state. The California Clinical Laboratory Association (CCLA) took immediate steps to counter the proposals. “This was a budget issue init…

Read More



Physician Management Companies Exploding, Will Transform Healthcare

CEO SUMMARY: Consolidation and integration of healthcare services will be the dominant trend during the next five years. It happened to commercial laboratories from 1985-95. Widespread hospital consolidation began around 1990 and continues today. Now consolidation is coming to physicians….

Read More



Dismal Hospital Finances Behind Lab Joint Venture

CEO SUMMARY: 1995 marked a pace-setting agreement between Columbia and LabCorp. LabCorp would consolidate and manage the laboratories at three Columbia Hospitals. All participants agree that the project has met expectations. But Columbia has yet to clone this model elsewhere. Here’s why…

Read More



Future Laboratory Model Found In Oklahoma City

CEO SUMMARY: Even as commercial laboratories struggle to maintain financial solvency, Urocor displays phenomenal growth in specimen volume, market share and revenue during the last five years. It is no accident that this laboratory is succeeding. Urocor’s executives use sophisticated ma…

Read More



Management Philosophy Drives UroCor’s Success

CEO SUMMARY: In the year 1997, UroCor shows a financial strength and growth potential unlike most commercial laboratories. UroCor’s current success is a direct result of how UroCor’s management did things differently during the years from 1991 to the present. Much of UroCor’s succes…

Read More



Market Assessment Leads Quest To Do Several Deals

CEO SUMMARY: Quest CEO Ken Freeman is moving rapidly to restructure Quest’s regional laboratory system. Using the financial head-start provided by the January spin-off from Corning, Inc., Quest purchased one laboratory and seeks to do joint venture deals in several cities. Quest’s act…

Read More



Pap Smear Technologies Battle For Market Share

CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three compan…

Read More



National Lab Strategies Will Impact Competitors

CEO SUMMARY: Not since the era of commercial lab consolidation ended has such a significant trend emerged. As the three national labs eliminate service to unprofitable accounts, profound changes will occur to the market for laboratory and pathology services. How quickly this leads to impr…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;